Trump re-nominates Musk ally Jared Isaacman for position of NASA chief

Former President Trump is in talks with Novo Nordisk, the maker of Ozempic, to negotiate a deal that could allow some weight-loss drugs to be sold for just $149. This move could also lead to Medicare and Medicaid coverage for these popular medications, benefiting many individuals seeking effective weight-loss solutions.

In a significant move, Trump has signed an order to reduce tariffs on fentanyl imports from China to 10%. This decision aims to address the ongoing opioid crisis by making it easier to access necessary resources while fostering better trade relations.

Lawmakers are expressing optimism about reaching a bipartisan agreement to end the government shutdown. Meanwhile, President Trump has reiterated his call for Republicans to bypass Democrats and reopen the government by ending the Senate filibuster.

The Norwegian opposition is creating hurdles for Elon Musk's ambitious plan to secure a $1 trillion pay deal, complicating his efforts and raising questions about the feasibility of such a massive financial arrangement.

The upcoming elections across states like New York and Virginia are set to reflect the electorate's mood regarding President Trump's second term. Voters will have the opportunity to express their opinions and influence the political landscape.

The Norway Wealth Fund, the largest sovereign wealth fund globally, has voted against Tesla's proposed $1 trillion pay package for Elon Musk. This decision raises questions about the implications for the upcoming shareholder vote, as discussed by Bloomberg's Craig Trudell with Caroline Hyde and Ed Ludlow.

Trump's recent visit to China has highlighted the shortcomings of his tariff strategies, showing that despite significant global repercussions, only limited progress has been achieved. This situation poses serious challenges for American businesses and consumers alike.

A judge has ruled that the Trump administration can revisit its approval of the SouthCoast Wind project. This decision opens the door for potential changes to the project's status, reflecting ongoing discussions about renewable energy initiatives.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the stability of the sector.

Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the sector's resilience.

Aviat Networks reported a remarkable 21.4% increase in revenue for Q1 FY2026, surpassing market expectations. This growth highlights the company's strong performance and positive outlook in the telecommunications sector.

Stoke Therapeutics recently presented its Q3 2025 results, showcasing impressive revenue growth alongside significant advancements in its clinical programs. The company's progress highlights its commitment to developing innovative therapies, making it a key player in the biotechnology sector.

Amgen has reported a 12% increase in revenue for Q3 2025, prompting the company to raise its guidance due to strong product performance. This positive trend highlights the effectiveness of their strategies and the growing demand for their offerings.

Corsair's Q3 2025 slides indicate a strong growth trajectory, despite missing earnings forecasts. The company is navigating challenges while showcasing resilience in its performance.